Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapse. 1983

S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón

Patients with recurrent acute lymphoblastic leukemia were treated with daunorubicin (40 mg/m2/week X 4), vincristine (1.5 mg/m2/week X 4), and prednisone (40 mg/m2/day x 28). All of the patients had been treated with the same combination during the first induction treatment. Of 266 patients (221 children and 45 adults) treated in first relapse, 141 (53%) achieved complete remission (CR; 55% of the children and 44% of the adults). Of 61 patients who were re-treated with the same combination after the second relapse, 14 (23%) achieved CR. The difference between second and third CR was statistically significant (P less than 0.0005). The median durations of second and third CR were 8 and 6 weeks, respectively. No significant difference was observed when the duration of CR was compared with the initial wbc count, age at diagnosis, or duration of first CR.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
February 1995, Annals of hematology,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
February 1978, Cancer,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
January 1977, Oncology,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
April 1973, Cancer,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
January 1979, Medical and pediatric oncology,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
January 1976, Medical and pediatric oncology,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
April 2000, Cancer,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
February 1977, Cancer research,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
November 1978, Archives of internal medicine,
S Pavlovsky, and F S Muriel, and M Eppinger-Helft, and P Bustelo, and G Garay, and J M Giuntoli, and R Kvicala, and J Divito, and A Picón
January 1984, Sangre,
Copied contents to your clipboard!